MARSHALL WACE, LLP - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 59 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q1 2019$46,000
-98.2%
9,058
-98.3%
0.00%
-100.0%
Q3 2018$2,580,000
+677.1%
531,868
+1318.3%
0.01%
-21.4%
Q1 2018$332,00037,5000.01%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q2 2019
NameSharesValueWeighting ↓
CAXTON CORP 6,612,065$15,803,00017.82%
Prosight Management, LP 2,515,072$6,011,0003.33%
22NW, LP 804,410$1,923,0002.54%
Broadfin Capital, LLC 2,578,003$6,161,0001.14%
NEA Management Company, LLC 4,141,308$9,898,0000.82%
Opaleye Management Inc. 490,000$1,171,0000.42%
PA Capital LLC 152,977$366,0000.36%
683 Capital Management, LLC 923,700$2,208,0000.25%
ESSEX INVESTMENT MANAGEMENT CO LLC 414,982$992,0000.14%
Hudson Bay Capital Management LP 1,475,000$3,525,0000.10%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders